Ocular complications of HIV infection in Sub-Sahara Africa

Current HIV/AIDS Reports

Volumn 5, Issue 3, 2008, Pages 120-125

  Nkomazana, Oathokwa ^a   Tshitswana, Dintle ^a  

^a BOTSWANA UPENN PARTNERSHIP   (Botswana)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; CIDOFOVIR; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; FLUOROURACIL; FOSCARNET; GANCICLOVIR; MITOMYCIN C; VALGANCICLOVIR;

ABDUCENS NERVE PARALYSIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLINDNESS; BOTSWANA; CAUSE OF DEATH; COMBINATION CHEMOTHERAPY; CRANIAL NERVE PARALYSIS; CRYPTOCOCCAL MENINGITIS; EYE CANCER; EYE DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; MONOTHERAPY; MORBIDITY; OCULAR SURFACE SQUAMOUS NEOPLASIA; OPTIC NERVE ATROPHY; PAPILLEDEMA; PREVALENCE; RETINITIS; RETINOPATHY; RWANDA; SOUTH AFRICA; SYPHILIS; TANZANIA; TREATMENT OUTCOME; TUBERCULOSIS; UGANDA; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT; ZIMBABWE; AFRICA SOUTH OF THE SAHARA; CONJUNCTIVA TUMOR; EYE TUMOR; SQUAMOUS CELL CARCINOMA;

AFRICA SOUTH OF THE SAHARA; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; CYTOMEGALOVIRUS RETINITIS; EYE DISEASES; EYE NEOPLASMS; HIV INFECTIONS; HUMANS; MENINGITIS, CRYPTOCOCCAL;

EID: 48949106983     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-008-0019-z     Document Type: Article

References (48)

1. Joint United Nations Programme on HIV/AIDS: AIDS Epidemic Update. Geneva: World Health Organization; 2007. Available at http://data.unaids.org/ pub/EPISlides/2007/2007_epiupdate_en.pdf. Accessed February 15, 2008.
2. Cunningham ET Jr, Margolis TP: Ocular manifestations of HIV infection. N Engl J Med 1998, 339:236-244.
3. HIV/AIDS: what is the impact on prevention of blindness programmes. Community Eye Health 2003, 16:33-34.
4. Jaffar S, Ariyoshi K, Frith P, et al: Retinal manifestations of HIV-I and HIV-2 infections among hospital patients in The Gambia, West Africa. Trop Med Int Health 1999, 4:487-492.
5. Assefa Y, Yohannes A, Melese A: Ocular manifestations of HIV/AIDS patients in Gondar University Hospital, North West Ethiopia. Ethiop J Health Dev 2006, 20:166-169.
6. Ndoye NB, Sow PS, Ba EA, et al.: Ocular complications of AIDS in Dakar. Dakar Med 1993, 38:97-100.
7. Gichuhi S, Irlam JJ: Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals. Cochrane Database Syst Rev 2007, 2:CD005643.
8. Poole TR: Conjunctival squamous cell carcinoma in Tanzania. Br J Ophthalmol 1999, 83:177-179.
9. Chisi SK, Kollmann MK, Karimurio J: Conjunctival squamous cell carcinoma in patients with human immunodeficiency infection seen at two hospitals in Kenya. East Afr Med J 2006, 83:267-270.
10. Semo B, Bison G, Nkomazana O: Immune status of HIV-positive patients with ocular surface squamous neoplasia in Botswana [abstract 27]. Presented at the 8th International Conference on Malignancies in HIV and Other Immunodeficiencies. Bethesda, MD; April 29-30, 2004.
11. Waddell KM, Lewallen S, Lucas SB, et al.: Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 1996, 80:503-508.
12. Ateenyi-Agaba C: Conjunctival squamous-cell carcinoma associated with HIV 1 infection in Kampala, Uganda. Lancet 1995, 345:695-696.
13. Guramatunhu S: Squamous cell carcinoma in HIV/AIDS. Community Eye Health 2003, 16:37.
14. Waddell KM, Downing RG, Lucas SB, Newton R: Corneoconjunctival carcinoma in Uganda. Eye 2006, 20:893-899.
15. Mahomed A, Chetty R: Human immunodeficiency virus infection, Bc1-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Ach Ophthalmol 2002, 120:554-558.
16. Kiire CA, Dhillon B: The aetiology and associations of conjunctival intraepithelial neoplasia. Br J Ophthalmol 2006, 90:109-113.
17. Ateenyi-Agaba C, Dai M, Le Calvez F, et al.: TP53 mutations in squamous carcinomas of the conjunctiva: evidence for UV-induced mutagenesis. Mutagenesis 2004, 19:399-401.
18. Newton R, Ferlay J, Reeves G, et al.: Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet 1996, 347:1450-1451.
19. Tornesello ML, Duraturo ML, Waddell KM, et al.: Evaluating the role of human papillomaviruses in conjunctival neoplasia. Br J Cancer 2006, 94:446-449.
20. Frucht-Pery J, Sugar J, Baum J, et al.: Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multi-center experience. Ophthalmology 1997, 104:2085-2093.
21. Sudesh S, Rapuano CJ, Cohen E, et al.: Surgical management of ocular surface squamous neoplasia: the experience from a cornea center. Cornea 2000, 19:278-283.
22. Jabs DA, Enger C, Bartlett JG: Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1997, 107:75-80.
23. Heiden D, Nathan W, Rodriguez WR, et al.: Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med 2007, 4:e334.
24. Jacobson M: Clinical manifestations and diagnosis of AIDS related cytomegalovirus retinitis. Up To Date 2007, 16:1. Available at http://www.uptodate.com/patients/content/topic. do?topicKey=hiv_infe/6396. Accessed February 15, 2008.
25. Kestelyn P: The epidemiology of CMV retinitis in Africa. Ocul Immunol Inflamm 1999, 7:3-4.
26. Jaffar S, Ariyoshi K, Frith P, et al.: Retinal manifestations of HIV-1 and HIV-2 infections among hospital patients in the Gambia, West Africa. Trop Med Int Health 1999, 4:487-492.
27. Cochereau I, Mlika-Cabanne N, Godinaud P, et al.: AIDS related eye disease in Burundi, Africa. Br J Ophthalmol 1999, 83:339-342.
28. Lewallen S, Kumwenda J, Maher D, et al.: Retinal findings in Malawian patients with AIDS. Br J Ophthalmol 1994, 78:757-759.
29. Beare NA, Kublin JG, Lewis DK, et al.: Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol 2002, 86:1076-1079.
30. Visser L: Managing CMV retinitis in the developing world. Community Eye Health 2003, 16:38-39.
31. Nkomazana O, Semo B: Outcome of CMV retinitis treatment in Botswana [poster]. Poster presented at the International AIDS Conference. Bangkok, Thailand; July 11-16, 2004.
32. Sugar AM: Overview of cryptococcosis in the patient with AIDS. Mycopathologia 1991, 114:153-157.
33. Heyderman RS, Gangaidzo IT, Hakim JG, et al: Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 1998, 26:284-289.
34. Mayanja-Kizza H, Oishi K, Mitarai S, et al.: Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis 1998, 26:1362-1366.
35. Okongo M, Morgan D, Mayanja B, et al.: Causes of death in a rural population-based human immunodeficiency virus 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol 1998, 27:698-702.
36. Kestelyn P, Taelman H, Bogaerts J, et al.: Ophthalmic manifestations of infections with cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1993, 116:721-727.
37. Bisson G, Nthobatsang R, Thakur R, et al.: The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in HIV-infected adults in Botswana [poster]. Poster presented at the 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3-6, 2008.
38. Mylonakis E, Merriman NA, Rich JD, et al.: Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis. Diagn Microbiol Infect Dis 1999, 34:111-114.
39. Bach MC, Tally PW, Godofsky EW: Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurgery 1997, 41:1280-1282.
40. Claus JJ, Portegies P: Reversible blindness in AIDS-related cryptococcal meningitis. Clin Neural Neurosurg 1998, 100:51-52.
41. Sukla D, Rathinam SF, Cunningham ET, et al.: Contribution of HIV/AIDS to global blindness. Int Ophthalmol Clin 2007, 47:27-43.
42. World Health Organization: Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: World Health Organization; 2008.
43. Bouza E, Merino P, Munoz P, et al.: Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore) 1997, 76:53-61.
44. Kestelyn PG, Cunningham ET Jr: HIV/AIDS and blindness. Bull World Health Organ 2001, 79:208-213.
45. Kestelyn PG, Lewallen S: Ocular problems with HIV infection and AIDS in Africa. Community Eye Health, 1995, 8:20-23.
46. Resnikoff S, Pascolini D, Etya'ale D, et al.: Global data on visual impairment in the year 2002. Bull World Health Organ 2004, 82:844-851.
47. Lewallen S, Courtright P: Blindness in Africa: present situation and future needs. Br J Ophthalmol 2001, 85:897-903.
48. Guex-Crosier Y, Telenti A: An epidemic of blindness: a consequence of improved HIV care? Bull World Health Organ 2001, 79:181.